CRISPR Therapeutics
CRSP
#2506
Rank
$5.47 B
Marketcap
$68.16
Share price
-2.85%
Change (1 day)
55.44%
Change (1 year)

P/S ratio for CRISPR Therapeutics (CRSP)

P/S ratio as of March 2024 (TTM): 14.8

According to CRISPR Therapeutics's latest financial reports and stock price the company's current price-to-sales ratio (TTM) is 14.7881. At the end of 2023 the company had a P/S ratio of 13.4.

P/S ratio history for CRISPR Therapeutics from 2016 to 2023

PS ratio at the end of each year

Year P/S ratio Change
202313.4-99.82%
2022> 1000114832.63%
20216.35-99.97%
2020> 1000156961.57%
201912.8-97.3%
20184741956.93%
201723.1-85.24%
2016156

P/S ratio for similar companies or competitors

Company P/S ratio P/S ratio differencediff. Country
N/AN/A๐Ÿ‡บ๐Ÿ‡ธ USA